Profile data is unavailable for this security.
About the company
Warby Parker Inc. is a lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. It offers holistic vision care by selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. It sells a range of prescription and non-prescription eyewear, including glasses, sunglasses, and contact lenses. Its customers can customize their prescription lenses with a variety of options, including single-vision, progressive, light-responsive, blue-light-filtering, and non-prescription lenses. It also offers in-house technologies like Virtual Vision Test and Virtual Try-On to enhance the overall customer experience. It sells its own brand of contacts, Scout by Warby Parker, and third-party contact lenses; this allows it to provide customers a vision care offering. Its Website and mobile app make it easy for its customers to browse, virtually try on, and purchase glasses.
- Revenue in USD (TTM)697.80m
- Net income in USD-55.06m
- Incorporated2009
- Employees2.14k
- LocationWarby Parker Inc233 Spring Street, 6Th Floor EastNEW YORK 10013United StatesUSA
- Phone+1 (646) 847-7215
- Fax+1 (302) 636-5454
- Websitehttps://www.warbyparker.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AtriCure Inc | 414.60m | -37.23m | 1.08bn | 1.20k | -- | 2.36 | -- | 2.60 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| MiMedx Group Inc | 334.51m | 71.52m | 1.10bn | 895.00 | 19.77 | 7.06 | 13.80 | 3.29 | 0.3767 | 0.3393 | 2.15 | 1.06 | 1.72 | 2.82 | 6.58 | 373,754.20 | 41.80 | -4.14 | 53.13 | -5.90 | 83.50 | 83.61 | 24.36 | -2.70 | 2.71 | 9.00 | 0.111 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| Adapthealth Corp | 3.25bn | -695.41m | 1.30bn | 10.70k | -- | 0.8811 | -- | 0.3987 | -5.18 | -5.18 | 24.27 | 10.97 | 0.6637 | 21.66 | 8.30 | 303,555.90 | -14.15 | -4.34 | -15.82 | -4.89 | 18.45 | 18.28 | -21.32 | -6.47 | 1.11 | 41.09 | 0.6025 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Owens & Minor, Inc. | 10.42bn | -38.77m | 1.43bn | 13.70k | -- | 1.59 | 5.66 | 0.1367 | -0.5099 | -0.5099 | 136.98 | 11.71 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Inmode Ltd | 466.26m | 181.11m | 1.53bn | 581.00 | 8.59 | 1.83 | 8.43 | 3.28 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| Establishment Labs Holdings Inc | 155.79m | -82.76m | 1.54bn | 781.00 | -- | 27.02 | -- | 9.86 | -3.15 | -3.15 | 5.91 | 2.07 | 0.6095 | 0.9191 | 3.39 | 171,579.30 | -32.38 | -33.22 | -39.25 | -41.12 | 65.01 | 64.73 | -53.12 | -43.19 | 2.73 | -21.30 | 0.7715 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| Alphatec Holdings Inc | 511.63m | -191.60m | 1.61bn | 839.00 | -- | 43.69 | -- | 3.15 | -1.49 | -1.49 | 3.97 | 0.4294 | 0.7612 | 1.34 | 6.70 | 609,808.10 | -28.51 | -30.97 | -37.13 | -39.47 | 65.89 | 66.02 | -37.45 | -46.22 | 1.49 | -5.17 | 0.8938 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| LeMaitre Vascular Inc | 199.89m | 33.95m | 1.71bn | 614.00 | 50.44 | 5.51 | 39.28 | 8.55 | 1.51 | 1.51 | 8.89 | 13.81 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | -- | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Warby Parker Inc | 697.80m | -55.06m | 1.76bn | 2.14k | -- | 5.55 | -- | 2.52 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| UFP Technologies Inc | 407.33m | 47.88m | 2.00bn | 3.09k | 41.95 | 6.77 | 33.57 | 4.90 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1033 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Premier Inc | 1.34bn | 80.33m | 2.04bn | 2.80k | 30.37 | 1.06 | 10.38 | 1.53 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| STAAR Surgical Co | 326.24m | 15.30m | 2.08bn | 1.06k | 136.91 | 5.30 | 100.53 | 6.38 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Conmed Corp | 1.26bn | 82.35m | 2.19bn | 4.00k | 27.14 | 2.56 | 14.20 | 1.74 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Patterson Companies, Inc. | 6.57bn | 193.86m | 2.27bn | 7.60k | 12.47 | 2.35 | 8.09 | 0.3452 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
| Helen of Troy Limited | 2.01bn | 168.59m | 2.44bn | 1.93k | 14.52 | 1.49 | 11.08 | 1.22 | 7.05 | 7.05 | 83.65 | 68.94 | 0.6971 | 2.48 | 5.19 | 1,040,503.00 | 5.86 | 7.69 | 6.90 | 9.53 | 47.31 | 44.32 | 8.41 | 9.24 | 0.9936 | 5.27 | 0.289 | -- | -3.26 | 5.09 | 17.67 | -0.6548 | 6.79 | -- |
Data as of May 11 2024. Currency figures normalised to Warby Parker Inc's reporting currency: US Dollar USD
62.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| D1 Capital Partners LPas of 31 Dec 2023 | 14.94m | 15.19% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 8.55m | 8.70% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 8.45m | 8.59% |
| Durable Capital Partners LPas of 31 Dec 2023 | 6.41m | 6.52% |
| Baillie Gifford & Co.as of 31 Mar 2024 | 6.08m | 6.18% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 5.81m | 5.91% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 5.08m | 5.16% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.09m | 2.13% |
| Rock Springs Capital Management LPas of 31 Dec 2023 | 2.03m | 2.06% |
| Geode Capital Management LLCas of 31 Dec 2023 | 1.69m | 1.72% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
